RNAi therapeutics (Alnylam/Ionis)

N/A

Report date: 2022/02/08 10:39:48
NME

Base Information

Drug NameRNAi therapeutics (Alnylam/Ionis)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAntithrombin-III inhibitorsRNA interference
TargetsAntithrombin-III
Therapy Area/IndicationsVenous ThromboembolismAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals IncIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedison PharmaIonis Pharmaceuticals IncAlnylam Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsVenous ThromboembolismAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A